WPI’s US Lovenox market share in 2Q12 was about 10% (up from 2% in 1Q12), according to today’s WPI CC. (WPI sells Lovenox into the retail channel only.)
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”